SEARCH

MEDIA PACK

NEWS

Current Edition

antiviral

ViiV trials long-acting, two-drug HIV regimen

ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults with HIV-1 …

29 November 2017 Uncategorized antiviral HIV

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

SEARCH

MENU

Current Edition

ViiV trials long-acting, two-drug HIV regimen

Journal for Clinical Studies